T3X Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Telix Pharmaceuticals Ltd

Watchlist Manager

Watchlist

Price: 10.294 EUR 1.22% Market Closed

Market Cap: €3.5B

	Telix Pharmaceuticals Ltd F:T3X	AU
	Platt Nera International Ltd HKEX:1949	TH
	Puig Brands SA F:B1B	ES
	Solventum Corp F:KB7	US
C	CMS Energy Corp XMUN:CSG	US
	Rarex Ltd ASX:REE	AU
H	Harfang Exploration Inc XTSX:HAR	CA
	Poste Italiane SpA F:7PI	IT
	Wide Open Agriculture Ltd F:2WO	AU

Profitability Summary

Telix Pharmaceuticals Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

48%

Strong 3Y Average Gross Margin

56%

Declining Gross Margin

62% > 48%

Low Operating Margin

Low 3Y Average Operating Margin

Operating Margin is Increasing

-7% > 7%

Low Net Margin

Low 3Y Average Net Margin

Net Margin is Increasing

-13% > 4%

Negative Free Cash Flow Margin

-7%

Negative 3Y Average Free Cash Flow Margin

-3%

Declining Free Cash Flow Margin

Positive 3Y Average ROIC

13%

ROIC is Increasing

-28% > 8%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.